New biomarkers on track for commercial launch in January 2025 Preliminary financial results indicate record full-year revenue and AVISE CTD trailing twelve-month ASP, with improvements to adjusted EBITDA and cash burn
Posted: 2025-01-12 17:00:00
Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeñaGlobe NewsWire News Distribution Service
Press Release: Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
New biomarkers on track for commercial launch in January 2025 Preliminary financial results indicate record full-year revenue and AVISE CTD trailing twelve-month ASP, with improvements to adjusted EBITDA and cash burn
Posted: 2025-01-12 17:00:00
Listen to this article. Speaker link opens in a new window.
More News From Current Category Plus Bonus Features From The Web
Press Release: Net Asset Value(s)
Mon, 07 Jul 2025 16:07:54 +00007 July 2025 HARGREAVE HALE AIM VCT PLC (the “Company”) NAV announcement As at close of business on 30 June 2025, the unaudited Net Asset Value (NAV) for Hargreave Hale AIM VCT plc was as follows: NAV per Ordinary share of 1p Cum Dividend – 36.43 pence.
Press Release: Johnson Fistel Begins Investigation on Behalf of BellRing Brands, Inc. (BRBR) Shareholders
Mon, 07 Jul 2025 13:07:58 +0000SAN DIEGO, July 07, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP, is investigating whether BellRing Brands, Inc. (NYSE: BRBR), or any of its executive officers, violated securities laws by misrepresenting or failing to timely disclose material information to investors.
Press Release: Allstate survey: Nearly one third of active social media users may potentially risk a home break-in by posting online before or during a vacation trip
Mon, 07 Jul 2025 10:07:50 +0000MARKHAM, Ontario, July 07, 2025 (GLOBE NEWSWIRE) -- Almost one third (32 per cent) of Canadian respondents to a survey that say they are active on social media post about their plans before or while traveling, a figure that rises to 51 per cent among those aged 18 to 34. Posting that beach vacation selfie…
Press Release: Christian Dior : Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Mon, 07 Jul 2025 07:07:49 +0000Société Européenne au capital de € 361 015 032 - 582 110 987 R.C.S Paris30 avenue Montaigne - 75008 Paris INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Press Release: Best Delta 8 Gummies of 2025: Area 52 Named #1 Edible by Oregon Observer
Mon, 07 Jul 2025 04:07:52 +0000Las Vegas, NV, July 06, 2025 (GLOBE NEWSWIRE) -- In a landmark achievement that solidifies Area 52's position as the Delta 8 market leader, The Oregon Observer's extensive 2025 cannabis edibles review has awarded the top Delta 8 gummy rankings to Area 52's innovative product line. This unprecedented sweep demonstrates the brand's unwavering commitment to…
Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results | Taiwan News | Jan ...
Sun, 12 Jan 2025 17:00:00 GMTPreliminary financial results indicate record full-year revenue and AVISE CTD trailing twelve-month ASP, with improvements to adjusted EBITDA and cash burn CARLSBAD, Calif., Jan. 12, 2025 (GLOBE ...
Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results - WRIC ABC 8News
Sun, 12 Jan 2025 09:00:00 GMTNew biomarkers on track for commercial launch in January 2025 Preliminary financial results indicate record full-year revenue and AVISE CTD trailing twelve-month ASP, with improvements to adjusted ...
Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results - KSN-TV
Sun, 12 Jan 2025 09:00:00 GMTNew biomarkers on track for commercial launch in January 2025 Preliminary financial results indicate record full-year revenue and AVISE CTD trailing twelve-month ASP, with improvements to adjusted ...
Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results
Sun, 12 Jan 2025 09:00:00 GMTNew biomarkers on track for commercial launch in January 2025 Preliminary financial results indicate record full-year revenue and AVISE CTD trailing twelve-month ASP, with improvements to adjusted ...
Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results - Markets Insider
Sun, 12 Jan 2025 04:00:00 GMTNew biomarkers on track for commercial launch in January 2025 Preliminary financial results indicate record full-year revenue and AVISE CTD trailing twelve-month ASP, with improvements to adjusted ...
Related Product Search/Búsqueda de productos relacionados
